US Stock MarketDetailed Quotes
ACRX AcelRx Pharmaceuticals
Watchlist
0.6850
-0.0338-4.70% Close 11/29 16:00 ET
0.7490+0.0640+9.34%
Post 16:02 ET
0.7134High0.6700Low148.32KVolume
0.7000Open0.7188Pre Close103.13KTurnover1.23%Turnover RatioLossP/E (TTM)11.61MMarket Cap2.780052wk High0.12P/E (Static)16.95MShares0.425052wk Low0.63P/B8.24MFloat Cap272.8000Historical High--Dividend TTM12.03MShs Float0.4250Historical Low--Div YieldTTM6.04%Amplitude0.6950Avg Price1Lot Size
About AcelRx Pharmaceuticals Company
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
Company Profile
SymbolACRX
Company NameAcelRx Pharmaceuticals
Listing Date02/11/2011
Issue Price5.00
Founded2005
CEOMr. Vincent J. Angotti
MarketNASDAQ
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1850 Gateway Drive,Suite 175
CitySan Mateo
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-216-3500
Websitehttp://www.acelrx.com
Company Executives
- Name
- Position
- Salary
- Vincent J. Angotti
- Director and Chief Executive Officer
- 1.30M
- Badri Dasu
- Chief Engineering Officer
- 734.21K
- Raffi Asadorian
- Chief Financial Officer and Principal Accounting Officer
- 755.14K
- Dr. Pamela P. Palmer, M.D.,PhD
- Director and Chief Medical Officer
- 822.40K
- Adrian Adams
- Chairman of the Board
- 111.50K
- Mark A. Wan
- Independent Director
- 76.50K
- Dr. Stephen J. Hoffman,M.D.,PhD
- Independent Director
- 56.50K
- Jill M. Broadfoot
- Independent Director
- 66.50K
- Howard B. Rosen
- Independent Director
- 59.00K
- Dr. Richard Afable, M.D.
- Independent Director
- 64.00K
- Marina Bozilenko
- Independent Director
- 66.50K